Skip Nav Destination
Dasatinib Stimulates Its Own Mechanism of Resistance by Activating a CRTC3/MITF/Bcl-2 Pathway in Melanoma with Mutant or Amplified c-Kit
Mol Cancer Res (2021) 19 (7): 1221–1233.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Malak Sabbah
- Ahmad Najem
- Christophe Vanderkerkhove
- Fabien Kert
- Younes Jourani
- Fabrice Journe
- Ahmad Awada
- Dirk Van Gestel
- Ghanem E. Ghanem
- Mohammad Krayem
Frontiers in Medicine (2023) 10
- Zhuzhu Wu
- Yifei Bian
- Tianjiao Chu
- Yuman Wang
- Shuai Man
- Yongmei Song
- Zhenguo Wang
Frontiers in Pharmacology (2022) 13
RSS Feeds